The aim of this study was to evaluate the effect of limb malformations on health-related quality of life (HRQL) and function of the extremities in middle-aged individuals with thalidomide embryopathy (TE). Between 1959 and 1962, approximately 150 children with multiple malformations were born in Sweden following the maternal intake of thalidomide during pregnancy, of whom 100 survived.
Thirty-one individuals with TE underwent evaluations of musculoskeletal manifestations by clinical examination. Validated questionnaires were used for the assessment of general HRQL [the 36-Item Short Form Health Survey (SF-36) and the EuroQ Five Dimensions health questionnaire (EQ-5D)]. The function of the upper and lower extremities was evaluated using specific questionnaires (Disabilities of the Arm, Shoulder and Hand scale and Rheumatoid and Arthritis Outcome Score, respectively). The lower limbs were evaluated by computed tomography. The median age of the study group was 46 years, and 42% were females. Twenty-five individuals had malformations of the hand, but 27 had a grip function. Five individuals had severe lower limb malformations. Individuals with at least one extremity with major malformation(s) that affected function (n = 15) were compared with those without (n = 16).
The physical HRQL for the entire study group [mean 40.6, 95% confidence interval (CI) 35.4–45.8], as evaluated by the Physical Composite Score (PCS) of the SF-36, was significantly lower than the national norm value (population-based norm) of 50.0, and the physical HRQL of the subgroup with major limb malformations (15/31) was even lower (mean 34.6, 95% CI 25.9–43.4). The mental aspects of HRQL, based on SF-36 and EQ-5D scores, were not affected in the entire study group or in the subgroups.
The physical quality of life was significantly lower in individuals with TE compared with the general national population, while the mental aspects were not affected.
McBride WG (1961) Thalidomide and congenital abnormalities. Lancet 1:45
Lenz W (1961) Childhood malformations after intake of medication during pregnancy. Dtsch Med Wochenschr 86:2555
Ghassemi Jahani SA, Danielson B, Karlsson J, Danielsson AJ (2014) Long-term follow-up of thalidomide embryopathy: malformations and development of osteoarthritis in the lower extremities and evaluation of upper extremity function. J Child Orthop 8(5):423–433. doi: 10.1007/s11832-014-0609-9 CrossRefPubMedPubMedCentral
Ghassemi Jahani SA, Danielsson A, Ab-Fawaz R, Hebelka H, Danielson B, Brisby H (2016) Degenerative changes in the cervical spine are more common in middle-aged Individuals with thalidomide embryopathy than in healthy controls. PLoS One 11(5):e0155493. doi: 10.1371/journal.pone.0155493 CrossRefPubMedPubMedCentral
Winberg J (1964) Investigation on the possible relation of fetal Injuries and drugs. IV. Retrospective study on drug consumption among mothers with malformed children. Svenska lakartidningen 61(814–831):890–902 (in Swedish) PubMed
Am D, Barr B (1964) Ear abnormalities and cranial nerve palsies in thalidomide children. Arch Otolaryngol 80:136–140 CrossRef
Zetterstrom B (1966) Ocular malformations caused by thalidomide. Acta Ophthalmol (Copenh) 44(3):391–395 CrossRef
Aitken GT (1969) A Proximal femoral focal deficiency-definition, classification, and management. In: Aitken GT (ed) Proximal femoral focal deficiency: a congenital anomaly. National Academy of Sciences, Washington, pp 1–22
Gillespie R, Torode IP (1983) Classification and management of congenital abnormalities of the femur. J Bone Jt Surg Br 65(5):557–568
Wiklund I (1993) Practical issues in the design and inclusion of quality of life in multicentre clinical trials. Br J Med Econ 6:45–48
Hudak PL, Amadio PC, Bombardier C (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med 29(6):602–608. doi: 10.1002/(SICI)1097-0274(199606)29:6<602:AID-AJIM4>3.0.CO;2-L CrossRefPubMed
Atroshi I, Gummesson C, Andersson B, Dahlgren E, Johansson A (2000) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: reliability and validity of the Swedish version evaluated in 176 patients. Acta Orthop Scand 71(6):613–618. doi: 10.1080/000164700317362262 CrossRefPubMed
Sullivan M, Karlsson J, Ware J (1994) SF-36, Swedish manual and interpretation guide. Gothenburg University and Sahlgrenska Hospital, Gothenburg
Glick HA, Polsky D, Willke RJ, Schulman KA (1999) A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Mak 19(3):265–275 CrossRef
Ware J, Snow K, Kosinski M, Gandek B (1993) SF-36 Health Survey: Manual and interpretation guide. The Health Institute, New England Medical Center, Boston
- Health-related quality of life and function in middle-aged individuals with thalidomide embryopathy
Shadi A. Ghassemi Jahani
Aina J. Danielsson
- Springer Berlin Heidelberg
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II